259 related articles for article (PubMed ID: 28167384)
1. A live-attenuated influenza vaccine for H3N2 canine influenza virus.
Rodriguez L; Nogales A; Reilly EC; Topham DJ; Murcia PR; Parrish CR; Martinez Sobrido L
Virology; 2017 Apr; 504():96-106. PubMed ID: 28167384
[TBL] [Abstract][Full Text] [Related]
2. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
[TBL] [Abstract][Full Text] [Related]
3. Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.
Nogales A; Rodriguez L; Chauché C; Huang K; Reilly EC; Topham DJ; Murcia PR; Parrish CR; Martínez-Sobrido L
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928017
[TBL] [Abstract][Full Text] [Related]
4. Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines.
Nogales A; Huang K; Chauché C; DeDiego ML; Murcia PR; Parrish CR; Martínez-Sobrido L
Virology; 2017 Jan; 500():1-10. PubMed ID: 27750071
[TBL] [Abstract][Full Text] [Related]
5. The inactivated vaccine of reassortant H3N2 canine influenza virus based on internal gene cassette from PR8 is safe and effective.
Liu Y; Fu C; Ye S; Liang Y; Qi Z; Yao C; Wang Z; Wang J; Cai S; Tang S; Chen Y; Li S
Vet Microbiol; 2021 Mar; 254():108997. PubMed ID: 33524810
[TBL] [Abstract][Full Text] [Related]
6. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel equine influenza virus live-attenuated vaccine.
Rodriguez L; Reedy S; Nogales A; Murcia PR; Chambers TM; Martinez-Sobrido L
Virology; 2018 Mar; 516():76-85. PubMed ID: 29331866
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589
[TBL] [Abstract][Full Text] [Related]
9. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
Li J; Arévalo MT; Chen Y; Chen S; Zeng M
Int J Infect Dis; 2014 Oct; 27():37-43. PubMed ID: 25172265
[TBL] [Abstract][Full Text] [Related]
10. Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States.
Willis E; Parkhouse K; Krammer F; Hensley SE
Vaccine; 2016 Nov; 34(46):5483-5487. PubMed ID: 27670073
[TBL] [Abstract][Full Text] [Related]
11. Serological survey for emerging canine H3N8 and H3N2 influenza viruses in pet and village dogs in Nigeria.
Oluwayelu DO; Bankole O; Ajagbe O; Adebiyi AI; Abiola JO; Otuh P; Omobowale OT
Afr J Med Med Sci; 2014 Dec; 43 Suppl():111-5. PubMed ID: 26949788
[TBL] [Abstract][Full Text] [Related]
12. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
13. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
[TBL] [Abstract][Full Text] [Related]
14. Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
Korenkov DA; Laurie KL; Reading PC; Carolan LA; Chan KF; Isakova-Sivak II; Smolonogina TA; Subbarao K; Barr IG; Villanueva J; Shcherbik S; Bousse T; Rudenko LG
Infect Genet Evol; 2018 Oct; 64():95-104. PubMed ID: 29929009
[TBL] [Abstract][Full Text] [Related]
15. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
Baz M; Paskel M; Matsuoka Y; Zengel JR; Cheng X; Treanor JJ; Jin H; Subbarao K
J Virol; 2015 Jul; 89(13):6907-17. PubMed ID: 25903333
[TBL] [Abstract][Full Text] [Related]
16. Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus.
Sun H; Blackmon S; Yang G; Waters K; Li T; Tangwangvivat R; Xu Y; Shyu D; Wen F; Cooley J; Senter L; Lin X; Jarman R; Hanson L; Webby R; Wan XF
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814512
[TBL] [Abstract][Full Text] [Related]
17. A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.
White CL; Chiem K; Perez DR; Santos J; Cardenas Garcia S; Nogales A; Martínez-Sobrido L
Viruses; 2021 Jun; 13(7):. PubMed ID: 34208979
[TBL] [Abstract][Full Text] [Related]
18. The K186E Amino Acid Substitution in the Canine Influenza Virus H3N8 NS1 Protein Restores Its Ability To Inhibit Host Gene Expression.
Nogales A; Chauché C; DeDiego ML; Topham DJ; Parrish CR; Murcia PR; Martínez-Sobrido L
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835506
[TBL] [Abstract][Full Text] [Related]
19. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.
Baz M; Paskel M; Matsuoka Y; Zengel J; Cheng X; Treanor JJ; Jin H; Subbarao K
J Virol; 2015 Feb; 89(3):1652-9. PubMed ID: 25410860
[TBL] [Abstract][Full Text] [Related]
20. Truncation of PA-X Contributes to Virulence and Transmission of H3N8 and H3N2 Canine Influenza Viruses in Dogs.
Liu L; Song S; Shen Y; Ma C; Wang T; Tong Q; Sun H; Pu J; Iqbal M; Liu J; Sun Y
J Virol; 2020 Jul; 94(15):. PubMed ID: 32461313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
